Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
08/20/2008 | CN101244244A Depression treating medicine composition and preparation method thereof |
08/20/2008 | CN101244231A Chinese medicine fragrant composition, its preparation and application |
08/20/2008 | CN101244221A Composition for external application and preparation method |
08/20/2008 | CN101244208A Method of preparing traditional Chinese medicine preparation for treating melancholia and anxiety neurosis |
08/20/2008 | CN101244197A Medicament for treating chronic migraine and general headache |
08/20/2008 | CN101244195A Medicament for treating aypnia |
08/20/2008 | CN101244169A Chinese medicine liqueur for treating difficult and complicated disease |
08/20/2008 | CN101244160A New anti-stress and tidepressant purpose of banana tegument extract |
08/20/2008 | CN101244154A Pharmaceutical combination for bearing and rearing better children, preventing birth defect and improving anamnesis |
08/20/2008 | CN101244127A Medicament for treating vascular dementia |
08/20/2008 | CN101244104A Method for increasing rare saponin content in panax ginseng total saponin extract |
08/20/2008 | CN101244087A Sheep insect powder for treating epilepsy |
08/20/2008 | CN101244084A Sobering-up agent of pearl oyster meat and preparation thereof |
08/20/2008 | CN101244080A Pharmaceutical combination for preventing birth defect and improving anamnesis |
08/20/2008 | CN101244074A Uses of epimedium brevicornum flavone and its active ingredient in preparing medicaments for accelerating neurocyte proliferation and differentiation function |
08/20/2008 | CN101244073A Panoxatriol saponin and caffeinum pharmaceutical combination, and uses thereof |
08/20/2008 | CN101244066A New purpose of total steroidal saponin extract |
08/20/2008 | CN101244026A Huperzine and its derivant or its salt implantation agent, its preparation method and application |
08/20/2008 | CN101243851A Nourishing kudzu root trunk (kudzu betel nut) formula and preparing process |
08/20/2008 | CN101243819A Method for preparing Jupu tea |
08/20/2008 | CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
08/20/2008 | CN100411687C Adhesive patch |
08/20/2008 | CN100411686C Visual function improving agents |
08/20/2008 | CN100411656C Application of cocoa ted extract in preparation of anti arteriosclerosis, antiageing medicine food and cosmetics |
08/20/2008 | CN100411655C Composition comprising panax ginseng and paullinia cupana extracts |
08/20/2008 | CN100411620C Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders |
08/20/2008 | CN100411618C Use of compounds that are effective as selective opiate receptor modulators |
08/20/2008 | CN100411611C Matrix for sustained, invariant and independent release of active compounds |
08/20/2008 | CN100411610C Liposome able to transmit blood and brain screen, medicinal compositions using hiposome as carrier and its preparation method |
08/19/2008 | US7414122 host cell, viral vector; agonists and antagonists; diagnosis or treatment of cancer; antiproliferative; infertility, miscarriage, preterm labor and delivery, and endometriosis; immunosuppressants; vaccine adjuvants; genetic mapping |
08/19/2008 | US7414107 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
08/19/2008 | US7414078 Oral general anesthetics and metabolitically resistant anticonvulsants |
08/19/2008 | US7414068 Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
08/19/2008 | US7414065 Methods to modulate conditions mediated by the CXCR4 receptor |
08/19/2008 | US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
08/19/2008 | US7414047 Piperazinyl and diazapanyl benzamides and benzthioamides |
08/19/2008 | US7414034 Administering antibody polynucleotide; controlling glutamate receptors |
08/19/2008 | US7413884 Using antibodies as hydrolysis catalysts; reducing concentration of amyloid plaque |
08/19/2008 | US7413747 Transdermal therapeutic system for treating Parkinsonism |
08/19/2008 | CA2501543C Enhancement of alcohol metabolism |
08/19/2008 | CA2488422C Stable solid medicinal ramosetron composition for oral administration |
08/19/2008 | CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
08/19/2008 | CA2390886C Use of fumaric acid derivatives for treating mitochondrial diseases |
08/19/2008 | CA2369448C Medicament for inhibiting nf-kb |
08/19/2008 | CA2268399C Anti-neurogenic inflammatory compounds and compositions and methods of use thereof |
08/19/2008 | CA2241469C Tetrahydroimidazo [2,1-a] isoquinoline derivatives |
08/19/2008 | CA2205134C A method for treating vascular headaches |
08/15/2008 | CA2621575A1 Drug detoxification protocol using microdosing |
08/14/2008 | WO2008098192A2 Compositions and methods for treating neuropathy |
08/14/2008 | WO2008098151A2 Polar hydrophilic prodrugs of amphetamine and other stimulants and processes for making and using the same |
08/14/2008 | WO2008097991A1 Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions |
08/14/2008 | WO2008097897A2 Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1(pai-1) |
08/14/2008 | WO2008097861A2 MODULATION OF NEUROGENESIS WITH BIGUANIDES AND GSK3-ß AGENTS |
08/14/2008 | WO2008097664A1 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile |
08/14/2008 | WO2008097546A2 Compounds that inhibit cholinesterase |
08/14/2008 | WO2008097536A2 Compositions and methods for treating psychiatric diseases and disorders |
08/14/2008 | WO2008097503A2 Use of semaphorin 6a for promoting myelination and oligodendrocyte differentiation |
08/14/2008 | WO2008096870A1 Aza-bridged-ring compound |
08/14/2008 | WO2008096829A1 Tricyclic compounds |
08/14/2008 | WO2008096791A1 Acylguanidine derivative |
08/14/2008 | WO2008096775A1 Therapeutic agent for pain disease |
08/14/2008 | WO2008096769A1 Pharmaceutical compositions containing substituted cercosporamide derivatives |
08/14/2008 | WO2008096755A1 Vanilloid receptor (vr1) inhibitor and use thereof |
08/14/2008 | WO2008096690A1 Polyethylene glycol derivative |
08/14/2008 | WO2008096359A2 Agents for the treatment of multiple sclerosis and methods of using same |
08/14/2008 | WO2008096129A1 Nitrogen containing hetrocyclic compounds useful as bifunctional modulators of m3 receptors and beta- 2 receptors |
08/14/2008 | WO2008096046A1 Noroxymorphone for use as a medicament |
08/14/2008 | WO2008096028A1 Glycosylate derivatives of mithramycin, method of preparation and uses thereof |
08/14/2008 | WO2008095943A1 The use of 7-azaindoles in the inhibition of c-jun n-terminal kinase |
08/14/2008 | WO2008095835A1 6-benzyl-2,3,4,7-tetrahydro-indolo [2, 3-c] quinoline compounds useful as pde5 inhibitors |
08/14/2008 | WO2008095773A1 Use of flibanserin for the treatment of insomnia |
08/14/2008 | WO2008095689A1 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands |
08/14/2008 | WO2008095366A1 Porphyrin derivatives, preparation methods and the uses as small molecular antioxidant thereof |
08/14/2008 | WO2008095297A1 Composition comprising terpene compounds and methods for inhibiting nerve transmission |
08/14/2008 | WO2008095275A1 Methods for the treatment of senile dementia of the alzheimer's type |
08/14/2008 | WO2008095253A1 Treatment of adhd |
08/14/2008 | WO2008095221A1 Treatment of adhd |
08/14/2008 | WO2008076810A3 Azabicyclic heterocycles as cannabinoid receptor modulators |
08/14/2008 | WO2008073350A3 Acetylene derivatives and their use for binding and imaging amyloid plaques |
08/14/2008 | WO2008071870A3 Use of agomelatine in order to obtain drugs intended for the treatment of smith-magenis syndrome |
08/14/2008 | WO2008071869A3 Use of agomelatine in order to obtain drugs intended for the treatment of periventricular leukomalacia |
08/14/2008 | WO2008071755A3 Casein-derived peptides having anxiolytic activity |
08/14/2008 | WO2008067390A9 Metabolites of 5-fluoro-8-{4-[4-(6-methoxyquinolin-8-yl)piperazin-1-yl]piperidin-1-yl} quinoline and methods of preparation and uses thereof |
08/14/2008 | WO2008044054A3 Hydroxy-substituted benzoic acid amide compounds for use in therapy |
08/14/2008 | WO2008041140A3 Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents |
08/14/2008 | WO2008033468A3 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
08/14/2008 | WO2008028903A3 Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer |
08/14/2008 | WO2007091250A3 Enzyme replacement therapy for treating lysosomal storage diseases |
08/14/2008 | US20080194797 Leucine-based motif and clostridial neurotoxins |
08/14/2008 | US20080194702 Obovatol Having Anti-Anxiety Activity |
08/14/2008 | US20080194695 Pharmaceutical Composition Containing Sibutramine Free Base and Manufacturing Method Thereof |
08/14/2008 | US20080194687 particle obtained by granulating 1-aminomethyl-cyclohexane-acetic acid with polyethylene glycol; antiepileptic agents |
08/14/2008 | US20080194684 administering lipid glycerides for treating neurodegenerative disease such as multiple sclerosis; increasing transforming growth factors and tumor necrosis factors |
08/14/2008 | US20080194683 Medicament for preventing and/or treating peripheral neuropathies |
08/14/2008 | US20080194672 Growth hormone secretagogue (ghrelin) receptor; gastrointestinal disorders; gastroesophageal reflux disease (GERD), gastric ulcers, Crohn's disease |
08/14/2008 | US20080194667 Compositions For Treating Amyloid Associated Diseases |
08/14/2008 | US20080194657 Thiazole Derivatives for Treating Restless Legs Syndrome |
08/14/2008 | US20080194656 Benzotriazole Derivatives as Cannabinoid Receptor Antagonists |
08/14/2008 | US20080194654 Using monoamine oxidase inhibitor; prevention, therapy of gastrointestinal disorders; sexual disorders; antidepressants; cognition activators; analgesics |